Patents by Inventor Bruce Chandler May

Bruce Chandler May has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF SEPSIS AND SYMPTOMS THEREOF
    Publication number: 20240000773
    Abstract: Certain embodiments described herein include methods and formulations for treating or preventing symptoms and conditions associated with sepsis. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: May 17, 2021
    Publication date: January 4, 2024
    Inventor: Bruce Chandler May
  • LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF CORONAVIRUS DISEASE AND SYMPTOMS THEREOF
    Publication number: 20230190734
    Abstract: Certain embodiments described herein include methods and formulations for treating or preventing symptoms and conditions associated with coronavirus disease (e.g., COVID-19). The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: December 15, 2022
    Publication date: June 22, 2023
    Inventor: Bruce Chandler May
  • Levocetirizine and montelukast in the treatment of inflammation mediated conditions
    Patent number: 11590125
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: February 28, 2023
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of autoimmune disorders
    Patent number: 11344545
    Abstract: The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: May 31, 2022
    Assignee: IRR, INC.
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY
    Publication number: 20220096465
    Abstract: The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: July 27, 2021
    Publication date: March 31, 2022
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of traumatic injury
    Patent number: 11103500
    Abstract: The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: August 31, 2021
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF INFLAMMATION MEDIATED CONDITIONS
    Publication number: 20210177835
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: August 31, 2020
    Publication date: June 17, 2021
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF VIRAL INFECTION CAUSED BY CORONAVIRUS
    Publication number: 20200323843
    Abstract: The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient. The combination can be useful during and following radiation exposure to ameliorate the inflammatory response.
    Type: Application
    Filed: June 4, 2020
    Publication date: October 15, 2020
    Inventor: Bruce Chandler May
  • Levocetirizine and montelukast in the treatment of inflammation mediated conditions
    Patent number: 10792281
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: October 6, 2020
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF ANAPHYLAXIS
    Publication number: 20200101067
    Abstract: The embodiments described herein include methods and formulations for treating anaphylaxis and related acute allergic reactions. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: September 30, 2019
    Publication date: April 2, 2020
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast to ameliorate inflammation following radiation exposure
    Patent number: 10537568
    Abstract: The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient. The combination can be useful during and following radiation exposure to ameliorate the inflammatory response.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: January 21, 2020
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST TO TREAT RHINOSINUSITIS AND NASAL POLYPOSIS
    Publication number: 20190298714
    Abstract: The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient. The combination can be useful during and following radiation exposure to ameliorate the inflammatory response.
    Type: Application
    Filed: April 11, 2019
    Publication date: October 3, 2019
    Inventor: Bruce Chandler May
  • LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF INFLAMMATION MEDIATED CONDITIONS
    Publication number: 20190201393
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: December 18, 2018
    Publication date: July 4, 2019
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF AUTOIMMUNE DISORDERS
    Publication number: 20190201392
    Abstract: The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: December 18, 2018
    Publication date: July 4, 2019
    Inventor: Bruce Chandler May
  • LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF RADIATION-MEDIATED CONDITIONS
    Publication number: 20190091218
    Abstract: Certain embodiments described herein include methods and formulations for treating or preventing symptoms and conditions associated with exposure to ionizing radiation and/or radiation generally. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: November 21, 2018
    Publication date: March 28, 2019
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of vasculitis
    Patent number: 10206919
    Abstract: The embodiments described herein include methods and formulations for treating vasculitis. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: February 19, 2019
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of autoimmune disorders
    Patent number: 10201537
    Abstract: The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: February 12, 2019
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • Levocetirizine and montelukast in the treatment of inflammation mediated conditions
    Patent number: 10195193
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: February 5, 2019
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY
    Publication number: 20180185357
    Abstract: The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: February 28, 2018
    Publication date: July 5, 2018
    Inventor: Bruce Chandler May
  • LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF INFLAMMATION MEDIATED CONDITIONS
    Publication number: 20180169091
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Application
    Filed: February 13, 2018
    Publication date: June 21, 2018
    Inventor: Bruce Chandler May